Venetoclax and azacitidine therapy in acute myeloid leukemia patients with severe renal impairment

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of hematology 2023-09, Vol.98 (9), p.E251-E254
Hauptverfasser:	Naka, Ryosuke, Kondo, Tadakazu, Nishikubo, Masashi, Muranushi, Hiroyuki, Ueda, Yasunori, Oka, Tomomi, Wada, Fumiya, Kanda, Junya, Yamamoto, Shohei, Watanabe, Mitsumasa, Okada, Shinri, Imada, Kazunori, Nakabo, Yukiharu, Mizutani, Yu, Nannya, Yasuhito, Ogawa, Seishi, Ishikawa, Takayuki
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute myeloid leukemia Antineoplastic Combined Chemotherapy Protocols - adverse effects Azacitidine - adverse effects Bridged Bicyclo Compounds, Heterocyclic - therapeutic use Hematology Humans Leukemia, Myeloid, Acute - chemically induced Leukemia, Myeloid, Acute - complications Leukemia, Myeloid, Acute - drug therapy Sulfonamides - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!